Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Bacterial Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03059992
What this trial is testing

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Who this might be right for
Invasive CandidiasisMucocutaneous CandidiasisCoccidioidomycosis+7 more
Scynexis, Inc. 233
Large-scale testing (Phase 3)Study completedNCT01371656
What this trial is testing

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Who this might be right for
Acute Leukemias of Ambiguous LineageBacterial InfectionDiarrhea+7 more
Children's Oncology Group 624
Not applicableStudy completedNCT07816510
What this trial is testing

Combination of Oral Antifungal Treatment for Refractory Dermatophytosis

Who this might be right for
Dermatophytosis
Chittagong Medical College 138
Post-approval studies (Phase 4)WithdrawnNCT00964041
What this trial is testing

Once Weekly D-cycloserine for Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Testing effectiveness (Phase 2)Looking for participantsNCT05807399
What this trial is testing

PanACEA - STEP2C -01

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 390
Large-scale testing (Phase 3)WithdrawnNCT06461949
What this trial is testing

Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray

Who this might be right for
Allergic Fungal Rhinosinusitis (AFRS)Chronic Rhinosinusitis (CRS)Asthma+1 more
National Institute on Deafness and Other Communication Disorders (NIDCD)
Not applicableLooking for participantsNCT05797649
What this trial is testing

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Who this might be right for
Pleural EffusionHeart FailureMalignant Neoplasm+5 more
Chinese University of Hong Kong 120
Not applicableActive Not RecruitingNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Not applicableAvailableNCT06433128
What this trial is testing

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica
Not applicableNot Yet RecruitingNCT06846645
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Who this might be right for
Single Cell Sequencing TechnologyGene Expression ProfilingGene Expression+7 more
Chinese University of Hong Kong 200
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Large-scale testing (Phase 3)Study completedNCT00056368
What this trial is testing

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Who this might be right for
Candidiasis
Pfizer 256
Not applicableStudy completedNCT00002325
What this trial is testing

Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

Who this might be right for
MycosesHIV InfectionsCoccidioidomycosis
Pfizer
Not applicableStudy completedNCT01725841
What this trial is testing

The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan

Who this might be right for
Enterobacteriaceae Infections
National Taiwan University Hospital 300
Not applicableActive Not RecruitingNCT07816523
What this trial is testing

Intergrated Service Delivery for Lung Health Conditions

Who this might be right for
TB - TuberculosisPTLDCOPD (Chronic Obstructive Pulmonary Disease)+1 more
Centre for Infectious Disease Research in Zambia 20,300
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Post-approval studies (Phase 4)Study completedNCT00481689
What this trial is testing

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens

Who this might be right for
Urinary Tract Infections
Bayer 500
Next Page